News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Andrew Delgado, PharmD

Articles by Andrew Delgado, PharmD

The Value of Novel Immuno-Oncology Treatments

ByJohn A. Romley, PhD,Andrew Delgado, PharmD,Jinjoo Shim, MS,Katharine Batt, MD

December 4th 2018

This study assesses the value of novel immuno-oncology treatments to society.

Latest Updated Articles

The Value of Novel Immuno-Oncology Treatments
Published: December 4th 2018 | Updated:

Trending on AJMC

FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis

HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.